Not Signed In -
Blood Diseases And Disorders |
|
|
Clinical Trial: Use of a Vibrotactile Sensory Prosthesis in Patients with Postural Imbalance and Spatial Disorientation.
This study is currently recruiting patients.
Verified by Imperial College London September 2005
|
Purpose
We propose to explore the hypothesis that vibrotactile channels for indicating spatial orientation can be exploited as a sensory prosthesis. The specific research applications will be for guiding visual orientation, to provide alternative feedback to vision and vestibular signals for controlling balance and for directional and lateralisation cueing in patients with neglect syndromes. The programme will study whether vibrotactile feedback improves performance and also it speeds rehabilitation when adjunct to conventional therapy.
| Condition | Intervention | Phase |
|---|---|---|
| Vestibular Diseases Peripheral Neuropathy Proprioceptive Disorders Hemineglects | Device: Vibro-tactile feedback | Phase I |
MedlinePlus related topics: Ear Disorders; Neurologic Diseases; Peripheral Nerve Disorders
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study
Official Title: Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients with Postural Imbalance and Spatial Disorientation.
Further Study Details:
Primary Outcomes: Mean Time reaction to the perturbation with the feedback.
Expected Total Enrollment: 30
Expected Total Enrollment: 30
Study start: January 2005; Expected completion: December 2007
Last follow-up: January 2006; Data entry closure: December 2006
Eligibility
Ages Eligible for Study: 50 Years - 80 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Sensory impairments
- Unsteadiness
Exclusion Criteria:
- high strokes
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00146952
Michael A Gresty, Pr 020-8846 Ext. 7634 m.gresty@imperial.ac.uk
Francois B Asseman, Dr 020-8383 Ext. 5525 f.asseman@imperial.ac.uk
Francois B Asseman, Dr 020-8383 Ext. 5525 f.asseman@imperial.ac.uk
United Kingdom
Charing cross hospital, London, W6 8RF, United Kingdom; Recruiting
Michael A Gresty, Pr 020-8846 Ext. 7634 m.gresty@imperial.ac.uk
Francois B Asseman, Dr 020-8383 Ext. 5525 f.asseman@imperial.ac.uk
Michael A Gresty, Pr, Principal Investigator
Francois B Asseman, Dr, Sub-Investigator
Francois B Asseman, Dr 020-8383 Ext. 5525 f.asseman@imperial.ac.uk
Michael A Gresty, Pr, Principal Investigator
Francois B Asseman, Dr, Sub-Investigator
Study chairs or principal investigators
Michael A Gresty, Pr, Principal Investigator, Imperial College London
Adolfo M Bronstein, Pr,MD, Study Director, Imperial College London
Christopher Kennard, Pr,MD, Study Director, Imperial College London
Masud Husain, Dr, Study Director, Imperial College London
More Information
Study ID Numbers: DNMCA-PR1077
Last Updated: September 6, 2005
Record first received: September 5, 2005
ClinicalTrials.gov Identifier: NCT00146952
Health Authority: United Kingdom: Research Ethics Committee
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 6, 2005
Record first received: September 5, 2005
ClinicalTrials.gov Identifier: NCT00146952
Health Authority: United Kingdom: Research Ethics Committee
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Blood Diseases And Disorders (National Women's Health Information Center)
- Blood Disorders in Lupus (Lupus Foundation of America, Inc.)
email this page
print this page
bookmark this page
feedback on this page
